The Royal Marsden NHS Foundation Trust tenders

To provide an independent, practical and NHSE/HMT-aligned assessment of the regulatory, legal, employment, commercial and tax risks and mitigations associated with the proposed wholly owned subsidiary (WOS)

Contract for Netspot Kits required by the trust

The Royal Marsden is currently exploring alternative operating models for its microbiology services and is undertaking a market engagement exercise to gather insights from providers. The exercise is designed to be a fact-finding and there is no fo ....

The Laboratory at RMH is currently using these DNA adaptors for high throughput sequencing experiments.

These reagents are required to deliver a service. The adaptors have been validated for tests that RMH offers as part of the Molecular D ....

CAR-T treatment called Obecel developed to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r B-ALL) which has recently become available to patients. The decision which treatment is most suitable applicable to a specific ....

The Authority is seeking to procure a new Clinical Trial Data Management Solution. The primary objective of this solution is to provide an accessible and cost-effective service that enables The Royal Marsden to collect and manage clinical research ....

The purchasing of a Nonacus GALEAS HereditaryPlus panel and GALEAS HereditaryPlus Variant Calling with field application scientist support

The Laboratory at RMH is currently using these DNA adaptors for high throughput sequencing experiments. These reagents are required to deliver a service. The adaptors have been validated for tests that RMH offers as part of the Molecular Diagnostic s ....

The Laboratory at RMH is currently using these DNA adaptors for high throughput sequencing experiments. These reagents are required to deliver a service. The adaptors have been validated for tests that RMH offers as part of the Molecular Diagnostic s ....

for the the supply of paediatric bone marrow harvests- a highly specialist procedure that’s conducted in a limited number of Trusts within the UK for our cohort of Paediatric patients (under 12KG), under 5 other UK Trusts.